[Regulation of Smad7 gene by TGF-beta 1 in process of malignant transformation]

Yan-ying Huo1, Kai-tai Zhang, Bang-yin Li

  • 1Department of Molecular Toxicology, Beijing Institute of Radiation Medicine, Beijing 100850, P. R. China.

Abstract

Insights

Smad7 overexpression and reduced transforming growth factor-beta (TGF-β) responsiveness in lung cells may drive radiation-induced lung cancer. This study investigated Smad7 gene regulation by TGF-β1 during malignant transformation.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Context:

  • Transforming growth factor-beta (TGF-β) signaling is crucial in cell growth and proliferation.
  • Inhibition of TGF-β signaling can contribute to tumorigenesis.
  • Smad7 acts as an inhibitor of TGF-β signaling, and its dysregulation may disrupt this pathway.

Purpose:

  • To analyze Smad7 mRNA expression and its regulation by TGF-β1.
  • To investigate the role of Smad7 in the malignant transformation of BEP2D cells.
  • To understand the mechanism of radiation-induced lung cancer.

Summary:

  • Smad7 mRNA expression was analyzed in BEP2D and BERP35T-2 cells using Northern blot.
  • Cells were stimulated with TGF-β1 to observe Smad7 gene regulation.
  • Western blot was used to examine TGF-β1 expression levels.

Impact:

  • Results indicate Smad7 overexpression and decreased TGF-β1 responsiveness in radiation-induced lung cancer cells.
  • This suggests a potential mechanism for radiation-induced lung cancer development.
  • Findings contribute to understanding the molecular basis of lung cancer progression.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...